Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-04-01
著者
関連論文
- メチルプレドニゾロンパルス療法は小児ステロイド白内障発症の危険因子である
- A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate
- Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
- 若年性関節リウマチにおける結成ヒアルロン酸値の診断的意義の検討
- Acute theumatic fever and poststreptococcal acute glomerulonephritis caused by T serotype 12 Streptococcus
- 小児全身性エリテマトーデス(SLE)の治療におけるミゾリビン(MZR)の効果
- Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjogren's syndrome
- Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis